Down Syndrome Screening in Pregnancies Conceived after Assisted Reproductive Technologies

10.5772/19304 ◽  
2011 ◽  
Author(s):  
Maarit Sahraravand ◽  
Markku Ryynane
Keyword(s):  
Down Syndrome ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Down Syndrome Screening

Down syndrome maternal serum markers in oocyte donation and other assisted reproductive technologies

2017 ◽  
Vol 37 (11) ◽  
pp. 1155-1159 ◽  
Author(s):  
Aurore Bonnin ◽  
Françoise Muller ◽  
Marie-Victoire Senat ◽  
Corinne Sault ◽  
Armelle Galland ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Oocyte Donation ◽  
Serum Markers ◽  
Maternal Serum

scholarly journals Inhibin as a reproductive biomarker part 2. Clinical significance of inhibins in reproductive medicine

2019 ◽  
Vol 68 (5) ◽  
pp. 91-106
Author(s):  
Zarina K. Abdulkadyrova ◽  
Maria I. Yarmolinskaya ◽  
Alexander M. Gzgzyan ◽  
Lyailya Kh. Dzhemlikhanova ◽  
Elena I. Abashova
Keyword(s):  
Down Syndrome ◽  
Ovarian Reserve ◽  
Reproductive Medicine ◽  
Prenatal Screening ◽  
Assisted Reproductive Technologies ◽  
Diagnostic Marker ◽  
Reproductive Function ◽  
Reproductive Technologies

In the early 2000s, the determination of inhibin levels was used actively for the diagnosis of ovarian tumors, as a diagnostic marker for prenatal screening of Down syndrome, as well as a prognostic marker for ovarian reserve when conducting assisted reproductive technologies. However, to date, inhibin is rarely used as a marker for reproductive function. At the same time, numerous studies of recent years indicate the crucial role of inhibin in folliculogenesis and spermatogenesis, as well as in implantation and placentation. This allows to significantly expand the diagnostic spectrum of inhibin levels in various disorders of the reproductive system of both women and men.

Re-imagining Reproduction: Unsettling Metaphors in the History of Imperial Science and Commercial Surrogacy in India

Somatechnics ◽  
2015 ◽  
Vol 5 (1) ◽  
pp. 88-103 ◽  
Author(s):  
Kalindi Vora
Keyword(s):  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
The Body ◽  
Body Parts ◽  
Colonial History ◽  
Women's Bodies ◽  
Commercial Surrogacy ◽  
Art Practices ◽  
History Of ◽  
Travel Industry

This paper provides an analysis of how cultural notions of the body and kinship conveyed through Western medical technologies and practices in Assisted Reproductive Technologies (ART) bring together India's colonial history and its economic development through outsourcing, globalisation and instrumentalised notions of the reproductive body in transnational commercial surrogacy. Essential to this industry is the concept of the disembodied uterus that has arisen in scientific and medical practice, which allows for the logic of the ‘gestational carrier’ as a functional role in ART practices, and therefore in transnational medical fertility travel to India. Highlighting the instrumentalisation of the uterus as an alienable component of a body and subject – and therefore of women's bodies in surrogacy – helps elucidate some of the material and political stakes that accompany the growth of the fertility travel industry in India, where histories of privilege and difference converge. I conclude that the metaphors we use to structure our understanding of bodies and body parts impact how we imagine appropriate roles for people and their bodies in ways that are still deeply entangled with imperial histories of science, and these histories shape the contemporary disparities found in access to medical and legal protections among participants in transnational surrogacy arrangements.

Sign in / Sign up

Export Citation Format

Share Document